Search

Search results

74 results found

Clinical Proof-of-concept of a Novel Platform Utilizing Biopsy-derived Live Single Cells, Phenotypic Biomarkers, and Machine Learning Toward a Precision Risk Stratification Test for Prostate Cancer Grade Groups 1 and 2 (Gleason 3 + 3 and 3 + 4).

The src-family kinase inhibitor PP2 suppresses the in vitro invasive phenotype of bladder carcinoma cells via modulation of Akt.

Chiang, George J, Brian R Billmeyer, David Canes, John Stoffel, Alireza Moinzadeh, Christina A Austin, Monika Kosakowski, Kimberly M Rieger-Christ, John A Libertino, and Ian C Summerhayes. 2005. “The Src-Family Kinase Inhibitor PP2 Suppresses the in Vitro Invasive Phenotype of Bladder Carcinoma Cells via Modulation of Akt.”. BJU International 96 (3): 416-22.

Histone deacetylase inhibitors upregulate plakoglobin expression in bladder carcinoma cells and display antineoplastic activity in vitro and in vivo.

Canes, David, George J Chiang, Brian R Billmeyer, Christina A Austin, Monika Kosakowski, Kimberly M Rieger-Christ, John A Libertino, and Ian C Summerhayes. 2005. “Histone Deacetylase Inhibitors Upregulate Plakoglobin Expression in Bladder Carcinoma Cells and Display Antineoplastic Activity in Vitro and in Vivo.”. International Journal of Cancer 113 (5): 841-8.

Vascular invasion identifies the most aggressive histologic subset of stage I lung adenocarcinoma: Implications for adjuvant therapy.

Yambayev, Ilyas, Travis B Sullivan, Kimberly M Rieger-Christ, Elliot L Servais, Cameron T Stock, Syed M Quadri, Jacob M Sands, Kei Suzuki, and Eric J Burks. 2022. “Vascular Invasion Identifies the Most Aggressive Histologic Subset of Stage I Lung Adenocarcinoma: Implications for Adjuvant Therapy.”. Lung Cancer (Amsterdam, Netherlands) 171: 82-89.

Pathologic and gene expression comparison of CT- screen detected and routinely detected stage I/0 lung adenocarcinoma in NCCN risk-matched cohorts.

Burks, Eric J, Jiarui Zhang, Travis B Sullivan, Xingyi Shi, Jacob M Sands, Shawn M Regis, Brady J McKee, et al. 2021. “Pathologic and Gene Expression Comparison of CT- Screen Detected and Routinely Detected Stage I/0 Lung Adenocarcinoma in NCCN Risk-Matched Cohorts.”. Cancer Treatment and Research Communications 29: 100486.